CalciMedica, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CALC research report →
About the company
CalciMedica, Inc. , a clinical-stage biotechnology company headquartered in La Jolla, California, is focused on creating treatments for life-threatening inflammatory diseases that currently lack adequate therapies. The company's proprietary approach involves blocking calcium release-activated (CRAC) channels, a mechanism designed to modulate the immune system and protect against cellular and tissue damage in these severe conditions.
- CEO
- A. Rachel Leheny
- IPO
- 2023
- Employees
- 14
- HQ
- La Jolla, CA, US
Price Chart
- Market Cap
- $15.25M
- P/E
- -0.74
- P/S
- 0.00
- P/B
- -13.13
- EV/EBITDA
- -0.39
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 4092.98%
- ROIC
- -674.61%
- Revenue
- $0 · 0.00%
- Net Income
- $-29,562,000 · -115.78%
- EPS
- $-1.97 · -61.48%
- Op Income
- $-23,121,000
- FCF YoY
- -0.25%
- 52W High
- $7.20
- 52W Low
- $0.46
- 50D MA
- $0.75
- 200D MA
- $2.27
- Beta
- 1.11
- Avg Volume
- 1.26M
Get TickerSpark's AI analysis on CALC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 25, 26 | Middleton Fred A | buy | 248,972 |
| Jun 25, 26 | Hebbar Sudarshan | other | 124,486 |
| Jun 25, 26 | WILSON ROBERT N | other | 1,182,621 |
| Jun 25, 26 | Roberts Eric W | other | 186,729 |
| Jun 25, 26 | Leheny A. Rachel | other | 186,729 |
| Apr 5, 25 | Bardin Stephen | other | 67,728 |
| Apr 5, 25 | Hebbar Sudarshan | other | 91,173 |
| Apr 5, 25 | Roberts Eric W | other | 83,358 |
| Apr 5, 25 | Dunn Michael J. | other | 65,124 |
| Apr 5, 25 | Stauderman Kenneth A. | other | 65,124 |
Our CALC coverage
Recent articles, reports, and earnings notes.
No research on CALC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CALC report →Similar companies
Peers in the same neighborhood.